All Stories

  1. Mutation of amino acids in SARS-CoV-2 may be responsible for CoV-2 vaccine long term inefficiency
  2. Biomedical Applications of Polyurethane Hydrogels, Polyurethane Aerogels, and Polyurethane-graphene Nanocomposite Materials
  3. Application of modified Michaelis – Menten equations for determination of enzyme inducing and inhibiting drugs
  4. Genetic diversity of canine parvovirus variants circulating in Nigeria
  5. Pro-fertility effects of hydroalcoholic extract of Psidium guajava leaves in female Wistar rats
  6. Modified formulas for calculation of encephalization: quotient in dogs
  7. Comparative therapeutic index, lethal time and safety margin of various toxicants and snake antivenoms using newly derived and old formulas
  8. Application of median lethal concentration (LC50) of pathogenic microorganisms and their antigens in vaccine development
  9. Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs
  10. Effects of Propofol Anaesthesia Pre-Medicated with Xylazine on Serum Biochemical Profiles and Sleep Pattern in Red Sokoto Goats
  11. Therapeutic effects of Byrsocarpus coccineus root bark extract on bacterially and chemically induced diarrhea in the Wistar albino rat (Rattus norvegicus domestica)
  12. Chemistry and Effects of Brainstem Acting Drugs
  13. Chirality of Central Nervous System (CNS) Acting Drugs: A Formidable Therapeutic Hurdle Against CNS Diseases
  14. Mathematical determination of some oncological parameters and their therapeutic implications in dogs
  15. Determination of median effective dose (ED50) of scorpion antivenom against scorpion envenomation using a newly developed formula
  16. The use of body surface area for determination of age, body weight, urine creatinine, plasma creatinine, serum creatinine, urine volume, and creatinine clearance: the reliable canonical method of assessing renotoxicity in animals
  17. Calculation of effective dose fifty (ED50) of antivenom for American pit viper envenomation
  18. Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs
  19. Phytochemical screening, proximate analysis, median lethal dose (LD50), hematological and biochemical effects of various extracts of Abrus precatorius seeds in Mus musculus
  20. In vivo Piroxicam Metabolites: Possible Source for Synthesis of Central Nervous System (CNS) Acting Depressants
  21. Functional Chemical Groups that May Likely Become a Source for the Synthesis of Novel Central Nervous System (CNS) Acting Drugs
  22. Piroxicam: Source for Synthesis of Central Nervous System (CNS) Acting Drugs
  23. Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats
  24. Effects of piroxicam on tissue distribution of sulfadimidine in West African Dwarf male and female goats
  25. Toxicity studies of drugs and chemicals in animals: an overview
  26. The Pattern of Sickle Cell Disease in Sickle Cell Patients from Northwestern Nigeria
  27. The new algorithm for calculation of median lethal dose (LD50) and effective dose fifty (ED50) of Micrarus fulvius venom and anti-venom in mice
  28. Physicochemical and structure-activity properties of piroxicam—a mini review
  29. The Paradox of Human Equivalent Dose Formula: A Canonical Case Study of Abrus Precatorius Aqueous Leaf Extract in Monogastric Animals
  30. Toxico-Neurological Effects of Piroxicam in Monogastric Animals
  31. Comparative Pharmacokinetics of Intramuscular Sulphadimidine in Non-starved and Starved Grower Turkeys (Meleagris gallopavo)
  32. A review on urolithiasis in dogs and cats
  33. A modified arithmetical method of Reed and Muench for determination of a relatively ideal median lethal dose (LD50)
  34. Haematonic and plasma expander effects of aqueous leaf extract of Abrus precatorius in Mus musculus
  35. A Photo Album of Some Medicinal Plants of the Nigerian Middle Belt
  36. Tropical Plants with Antihypertensive, Antiasthmatic, and Antidiabetic Value